Author: Chris Underdown

Varium™ Wins Best New Poultry Product Middle East at AgraME Awards

Posted on | by Chris Underdown

Varium™ Wins Best New Poultry Product Middle East at AgraME Awards

Dubai, UAE—The new non‐antibiotic growth promoter Varium™ was named Best New Poultry Product, Middle East at the AgraME Awards on March 14, 2016 at the Dubai International Convention and Exhibition Centre.

Varium is an innovative formulated feed additive that has been shown in clinical studies to promote growth in poultry equivalent to commonly used antiobiotics. It works by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

Acording to AgraME organizers, the award for Best New Product recognizes an exciting new poultry product that “demonstrates a prominent and far‐reaching competitive advantage, meets market needs through demand focus and offers improvements in cost efficiency.” All entered products were scored against key criteria surrounding leadership, features, innovation, performance, benefits, value and sustainability.

Produced by Amlan International, a leader in improving intestinal health in livestock, Varium has been shown to promote broiler growth equivalent to AGPs by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, strengthening the intestinal barrier function, and stimulating early immune function.

“We’re thrilled that Varium is being recognized for its potential as an AGP replacement and ability to enhance gut health and bird performance,” said Dr. Ron Cravens, President, Amlan International. “In clinical trials, Varium provided a 3:1 return on investment by improving feed conversion and reducing mortality. It also reduced the severity of Clostridium perfringens‐induced necrotic enteritis lesions, providing clear evidence of favorably impacting intestinal health and function.”

More information on Varium can be found at www.Amlan.com and a complete list of AgraME award winners can be found at http://www.agramiddleeast.com.

###

Amlan International, a division of Oil‐Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Varium™ Approved in Philippines for Necrotic Enteritis Treatment

Posted on | by Chris Underdown

Varium™ Approved in Philippines for Necrotic Enteritis Treatment

CHICAGO, IL—The Philippines Department of Agriculture, Bureau of Animal Industry recently approved Varium™ as a treatment for necrotic enteritis in poultry and as a tool to improve gut health, categorizing it as a performance enhancer that impacts feed efficiency, weight gain and lesion scores.

Produced by Amlan International, a leader in improving intestinal health in livestock, Varium™ is a unique new non‐antibiotic formulated product that acts like an antibiotic growth promoter (AGP). Results from multiple research studies showed that the product consistently reduced the effects of bacteria‐associated enteric disease, which has been estimated to cost the global poultry industry close to US$6 billion annually.

“In addition to achieving growth performance equivalent to commercial AGPs, Varium has been shown to lower Clostridium perfringens‐induced necrotic enteritis lesion scores, improve feed conversion, reduce mortality and support weight gain,” said Dr. Ron Cravens, President, Amlan International. “In clinical trials, Varium provided a ROI of 3:1 or higher.”

Interest in AGP alternatives that address bird intestinal health while enhancing performance is growing in light of the expanding global shift toward no antibiotics ever poultry production. In clinical studies, Varium promoted broiler growth equivalent to AGPs by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

More information on Varium can be found at www.Amlan.com. Watch the video for insight on intestinal health challenges and Varium’s mode of action.

###

About Amlan International

A wholly owned subsidiary of the Oil‐Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research overseen by its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

First Product Approved to Control Disease-Causing Bacterial Toxins

Posted on | by Chris Underdown

First Product Approved to Control Disease-Causing Bacterial Toxins

CHICAGO, IL—Amlan International announces that Calibrin-Z has been approved for use as an intestinal adsorbent for the control of disease-causing bacterial toxins from Argentina’s Ministry of Agriculture. Regulatory approval was granted after a review of Calibrin-Z’s extensive efficacy data, resulting in its status as the first product worldwide recognized to control bacterial toxins produced by pathogenic bacteria such as Clostridium perfringens, E. coli and Salmonella sp.

“Such an approval is a rarity, especially in such a challenging regulatory environment,” said Dr. Ron Cravens, President, Amlan International. “As the livestock industry continues to move away from using antibiotics as growth promoters, producers are beginning to realize the economic impact of toxins produced by pathogenic bacteria. Bacterial toxins cause notably greater economic loss to the global livestock industry than do mycotoxins and Calibrin-Z is positioned to offer an added level of proven protection for animals challenged with enteric diseases.”

More than 70 clinical studies and recent work from the USDA, demonstrate the product’s ability to adsorb bacterial toxins thereby reducing the effects of enteric diseases—a major source of economic loss in the livestock industry. The regulatory approval for Calibrin-Z is for poultry, swine, and cattle.

For more information on Calibrin-Z, visit www.Amlan.com

###

About Amlan International

A wholly owned subsidiary of the Oil-Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product to include alternatives to antibiotic growth promoters that improve intestinal health and function. Innovative research is conducted at its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of operations in Shenzhen, China. Further information on Amlan International is available at Amlan.com.

Amlan–Productivity for Life.

The product discussed here may not be available for sale and/or may not be registered and available in all countries where Amlan International is represented.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Launches NeoPrime™ to Improve Performance in Nursery Pigs

Posted on | by Chris Underdown

Amlan International Launches NeoPrime™ to Improve Performance in Nursery Pigs

CHICAGO, IL— Amlan International announces the launch of NeoPrime™, a new intestinal and immunity primer for weaning and post-weaning piglets. In clinical and farm usage studies, NeoPrime consistently delivered the equivalent of 5% more pig at finish due to combined improvements in feed conversion and weight gain.

Its unique formula improves post-weaning performance by reducing the level of pathogenic bacteria and biotoxins from the intestines, energizing and strengthening the cells that form the intestinal barrier, and stimulating passive and active immunities for the defense against pathogens.

“We know that intestinal health is essential for efficient conversion of feed to gain. The first phases of feeding are the most stressful for pigs, which can slow the development of a healthy intestinal environment and immune function,” said Dr. Ron Cravens, President, Amlan International. “NeoPrime is focused on getting pigs off to a strong start for a lifetime of good production.”

In addition to aiding in the digestion and absorption of nutrients, the intestinal environment forms a pig’s first line of defense against the harmful bacterial and fungal biotoxins, bacteria, or feed-associated antigens that can cause diarrhea, mal-absorption, and reduced growth and production.

Stressors surrounding the weaning period, such as separation from the sow, transition to dry food, and increased exposure to pathogens, are known to contribute to intestinal and immune dysfunctions that represent a major source of production losses in swine operations.

“Intestinal damage incurred during the post-weaning period can take as many as fifteen days to fully recover,” said Cravens. “NeoPrime works to stem this damage, and as a result we’ve seen farms with improvements in feed conversion and weight gain of 7.5% and 13.6% respectively.”

NeoPrime is currently approved for use in Japan, Thailand and the Philippines, and is waiting registration approval in multiple other countries in South America and the Asia-Pacific region.

###

Amlan International, a division of Oil-Dri Corporation of America (NYSE: ODC), helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research overseen by its

laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Launches AGP Alternative, Varium™

Posted on | by Chris Underdown

Amlan International Launches AGP Alternative, Varium™

 

CHICAGO, IL— Amlan International announces the launch of Varium™, a new non-antibiotic formulated product that acts like an antibiotic growth promoter (AGP) for poultry. In clinical studies Varium promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

“Research studies conducted with leading poultry collaborators in the U.S. showed that Varium consistently achieved growth performance equivalent to commercial AGPs and also reduced the effects of bacteria-associated enteric disease,” said Dr. Ron Cravens, President, Amlan International.

As the global poultry production community continues to shift to a no antibiotics ever approach in light of consumer and regulatory pressures, such as the FDA’s Veterinary Feed Directive, interest in AGP alternatives that address bird intestinal health while enhancing performance is growing.

Biotoxins produced by microorganisms such as Clostridium perfringens, E. coli, and Salmonella sp. damage the intestinal barrier, which reduces overall gut health and function thereby diverting energy from weight gain. Decreased gut function can also cause birds to suffer from lower feed conversion and increased mortality. By focusing on maintaining a healthy intestinal environment, producers are able to maximize the efficiency of their nutritional program.

“Varium has been shown to lower Clostridium perfringens induced Necrotic Enteritis lesion scores, improve feed conversion, reduce mortality and support weight gain,” said Cravens. “In fact, in clinical trials, Varium provided a ROI of 3:1 or higher by improving feed conversion and decreasing mortality.”

Varium is currently approved for use in Bolivia, Malaysia, Peru, the Philippines and Thailand, and is waiting registration approval in multiple other countries in South America, the Middle East and the Asia-Pacific region. For more information visit www.Amlan.com

 

###

About Amlan International

A wholly owned subsidiary of the Oil-Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP-alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Amlan International Researchers to Present Three Abstracts on Varium™ Performance at IPPE Scientific Forum

Posted on | by Chris Underdown

Amlan International Researchers to Present Three Abstracts on Varium™ Performance at IPPE Scientific Forum

CHICAGO, IL—Researchers from Amlan International in conjunction with scientists from the USDA and Southern Poultry Research will be presenting three abstracts during the IPPE Scientific Forum on Monday, January 25, 2016. The accepted abstracts are centered on the performance of Varium, a new formulated feed additive that promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

The first abstract, which will be presented by Amlan researchers Fang Chi, San Ching, LeAnn Johnston and Ron

Cravens, focuses on a study that supports improved feed conversion through Varium use. The second abstract, which details findings from Amlan researchers Ching, Johnston, Chi and Ed De Boer, as well as Dr. Hyun S. Lillehoj and Yeaseul Lim of the USDA in Beltsville, MD., discusses the ability of Varium to adsorb enteric disease agents responsible for significant economic losses. Decreasing the effects of necrotic enteritis through Varium inclusion is the topic of the third abstract, which will be presented by Amlan researchers Chi, Johnston, Cravens and Ching, along with Brett Lumpkins, Greg Mathis and Charles Hofacre of Southern Poultry Research in Athens, GA.

“We’re excited to present the results of several of our research studies that were conducted with leading poultry collaborators in the U.S.,” said Dr. Ron Cravens, President, Amlan International. “The data shows Varium consistently achieved growth performance equivalent to commercial AGPs and also reduced the effects of bacteria‐associated enteric disease.

The Scientific Forum, which is held from 8:00 AM to 5:00 PM in rooms B‐310 to 315 of the Georgia World Congress Center, is sponsored by the Southern Poultry Science Society, the Southern Conference on Avian Diseases, and U.S. Poultry & Egg Association. The forum presents information on industry topics such as environmental management, nutrition, physiology, pathology, processing and products, and avian diseases.

Find more information about the Scientific Forum and the International Production and Processing Expo at

IPPexpo.com.

###

About Amlan International

A wholly owned subsidiary of the Oil‐Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube

Lillehoj (USDA) and Collett (UGA) to Speak on Antibiotic Alternatives and Intestinal Health at Upcoming Seminar Hosted by Amlan International

Posted on | by Chris Underdown

Lillehoj (USDA) and Collett (UGA) to Speak on Antibiotic Alternatives and Intestinal Health at Upcoming Seminar Hosted by Amlan International

CHICAGO, IL.—Two of the recognized experts in the areas of the avian microbiome and the role bacteria play in the pathogenesis of disease, Dr. Hyun Lillehoj of the USDA and Stephen Collett from the University of Georgia, will be featured speakers at a technical seminar held on Wednesday, January 27th, 2016 at 10am at the Omni Atlanta Hotel at CNN Center, in downtown Atlanta, Georgia. Organized by animal health company Amlan International, this invitation‐only event is sure to spark discussion in light of the industry’s growing focus on the role of antibiotics.

Lillehoj, a 20 year veteran of the Agricultural Research Service (ARS) of the USDA at the Beltsville Agricultural Research Center, will be speaking about using dietary immunomodulation as a means to reduce the effects of enteric disease. Lillihoj is an international authority on avian health and has conducted considerable research on reducing the need for antibiotics to control enteric diseases.

Stephen R. Collett, a Clinical Associate Professor at the Poultry Diagnostic and Research Center (PDRC) in the College of Veterinary Medicine at The University of Georgia, will be speaking on dysbacteriosis and the role bacterial toxins play in disease. As a collaborative researcher at the PDRC, Collett focuses on managing the health of the digestive tract to maximize bird welfare, nutrient assimilation and performance.

“As a company focused on providing natural disease management solutions, we are thrilled to have the opportunity to learn from and collaborate with two of the greatest minds in the industry,” said Dr. Ron Cravens, President, Amlan International.

Following the two 1‐hour sessions, Amlan International will host a lunch reception to preview its new product, Varium, a new formulated feed additive that promotes broiler growth equivalent to antibiotics by reducing the level of pathogens and harmful biotoxins that damage the intestinal lining, stimulating early immune function, and strengthening the intestinal barrier function.

###

About Amlan International

A wholly owned subsidiary of the Oil‐Dri Corporation of America (NYSE: ODC), Amlan International helps producers increase animal productivity by developing products that enhance intestinal health and function. Since its inception in 2007, Amlan has grown its product offering across the intestinal health and AGP‐alternative market, driven largely by the research conducted in its laboratory campus in Vernon Hills, IL. In 2014, the company’s global reach expanded with the opening of China operations in Shenzhen. Further information on Amlan International is available at Amlan.com. Amlan–Productivity for Life.

Share this post:

Facebooktwittergoogle_plusredditpinterestlinkedinmail

Follow us:

Facebooktwittergoogle_pluslinkedinrssyoutube